Brooks Laboratories Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Brooks Laboratories Ltd?

Brooks Laboratories Ltd is trading at 54.50 as of 05 May 2026, with a FY2026-2027 high of 166 and low of 36.3. The stock is currently near its 52-week low. Market cap stands at 159 Cr..

Q: Is Brooks Laboratories Ltd financially healthy?

Key indicators: ROCE of 9.93 % is on the lower side. Dividend yield is 0.00 %.

Q: Is Brooks Laboratories Ltd profitable and how is the profit trend?

Brooks Laboratories Ltd reported a net profit of -10 Cr in Mar 2025 on revenue of 83 Cr. Compared to -19 Cr in Mar 2022, the net profit shows a mixed trend.

Fair Value

₹28.83Overvalued by 47.10%vs CMP ₹54.50

P/E (7.4) × ROE (12.2%) × BV (₹39.30) × DY (2.00%)

₹76.55Undervalued by 40.46%vs CMP ₹54.50

MoS: +28.8% (Adequate)Confidence: 38/100 (Low)Models: 3 Under, 3 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹47.89	34%	Over (-12.1%)
Graham Number	Earnings	₹80.51	20%	Under (+47.7%)
DCF	Cash Flow	₹182.27	16%	Under (+234.4%)
Net Asset Value	Assets	₹39.42	11%	Over (-27.7%)
Earnings Yield	Earnings	₹73.30	11%	Under (+34.5%)
Revenue Multiple	Revenue	₹28.45	8%	Over (-47.8%)
Consensus (6 models)		₹76.55	100%	Undervalued

Key Drivers: EPS CAGR 66.1% lifts DCF — verify sustainability. | Wide model spread (₹28–₹182) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 66.1%

*Investments are subject to market risks

Analyst Summary

Brooks Laboratories Ltd operates in the Pharmaceuticals segment, NSE: BROOKS | BSE: 533543, current market price is ₹54.50, market cap is 159 Cr.. At a glance, stock P/E is 7.37, ROE is 12.2 %, ROCE is 9.93 %, book value is 39.3, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹76.55, which is about 40.5% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹83 Cr versus the prior period change of 5.1%, while latest net profit is about ₹-10 Cr with a prior-period change of 50.0%. The 52-week range shown on this page is 166/36.3, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisBrooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(…

This summary is generated from the stock page data available for Brooks Laboratories Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Brooks Laboratories Ltd scores 57/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health42/100 · Moderate

ROCE 9.9% AverageROE 12.2% GoodD/E 0.35 ModerateInterest Coverage 0.0x RiskyProfitable 0/5 years Inconsistent

Smart Money60/100 · Moderate

FII holding up 0.04% (6mo) Slight increasePromoter holding at 52.6% Stable

Earnings Quality65/100 · Strong

OPM expanding (-32% → -16%) Improving

Quarterly Momentum70/100 · Strong

Revenue (4Q): +19% YoY GrowingOPM: 10.8% (up 27.2% YoY) Margin expansion

Industry Rank55/100 · Moderate

P/E 7.4 vs industry 60.2 Cheaper than peersROCE 9.9% vs industry 16.5% Average3Y sales CAGR: -3% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: May 4, 2026, 11:57 pm

Market Cap	159 Cr.
Current Price	54.5
Intrinsic Value	₹76.55
High / Low	166/36.3
Stock P/E	7.37
Book Value	39.3
Dividend Yield	0.00 %
ROCE	9.93 %
ROE	12.2 %
Face Value	10.0
PEG Ratio	0.11

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Brooks Laboratories Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Brooks Laboratories Ltd	159 Cr.	54.5	166/36.3	7.37	39.3	0.00 %	9.93 %	12.2 %	10.0
Auro Laboratories Ltd	154 Cr.	248	317/159	52.3	69.9	0.00 %	3.85 %	4.33 %	10.0
Gujarat Inject (Kerala) Ltd	154 Cr.	105	105/17.0	617	6.93	0.00 %	13.5 %	11.0 %	10.0
Coral Laboratories Ltd	151 Cr.	423	785/360	10.6	596	0.35 %	17.4 %	13.1 %	10.0
Alpa Laboratories Ltd	144 Cr.	67.3	120/46.0	12.2	92.0	0.00 %	15.0 %	11.5 %	10.0
Industry Average	20,594.11 Cr	1,138.87		60.16	202.22	0.35%	16.48%	15.27%	6.10

All Competitor Stocks of Brooks Laboratories Ltd

Quarterly Result

Metric	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	18.08	15.30	12.61	15.70	24.32	21.75	17.72	17.93	20.79	20.52	23.32	25.51	23.45
Expenses	27.30	23.85	16.31	19.61	25.42	25.12	27.25	19.85	24.20	22.02	24.58	22.38	20.93
Operating Profit	-9.22	-8.55	-3.70	-3.91	-1.10	-3.37	-9.53	-1.92	-3.41	-1.50	-1.26	3.13	2.52
OPM %	-51.00%	-55.88%	-29.34%	-24.90%	-4.52%	-15.49%	-53.78%	-10.71%	-16.40%	-7.31%	-5.40%	12.27%	10.75%
Other Income	0.40	0.45	0.03	0.05	0.09	0.16	0.65	0.07	0.20	0.03	0.62	7.15	6.13
Interest	0.63	0.75	0.18	0.17	0.19	0.21	0.27	0.16	0.32	0.28	0.26	0.30	0.28
Depreciation	2.28	2.33	0.44	0.44	0.44	0.43	0.46	0.40	0.43	0.38	0.39	0.39	0.39
Profit before tax	-11.73	-11.18	-4.29	-4.47	-1.64	-3.85	-9.61	-2.41	-3.96	-2.13	-1.29	9.59	7.98
Tax %	-32.82%	-15.21%	0.00%	0.00%	0.00%	0.78%	0.00%	0.00%	0.00%	0.00%	13.95%	0.00%	0.00%
Net Profit	-7.87	-9.48	-4.29	-4.47	-1.64	-3.88	-9.61	-2.41	-3.96	-2.13	-1.46	9.58	7.98
EPS in Rs	-1.79	-1.92	-1.64	-1.71	-0.62	-1.48	-3.66	-0.92	-1.51	-0.81	-0.50	3.25	2.71

Last Updated: January 2, 2026, 4:29 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 4:46 pm

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	77	91	63	79	83	89
Expenses	77	105	93	97	91	84
Operating Profit	1	-14	-30	-18	-8	5
OPM %	1%	-16%	-47%	-22%	-10%	6%
Other Income	1	1	1	1	1	19
Interest	3	3	2	1	1	1
Depreciation	7	7	7	2	2	2
Profit before tax	-9	-24	-38	-20	-10	22
Tax %	115%	-19%	-19%	0%	2%
Net Profit	-19	-19	-31	-20	-10	22
EPS in Rs	-7.40	-4.31	-7.97	-7.46	-3.38	7.33
Dividend Payout %	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	0.00%	-63.16%	35.48%	50.00%
Change in YoY Net Profit Growth (%)	0.00%	-63.16%	98.64%	14.52%

Brooks Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	-3%
TTM:	10%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	4%
TTM:	112%

Stock Price CAGR
10 Years:	10%
5 Years:	30%
3 Years:	3%
1 Year:	18%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	-22%
Last Year:	-12%

Last Updated: September 5, 2025, 1:25 am

Balance Sheet

Last Updated: December 4, 2025, 1:04 am

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	25	25	25	26	29	29
Reserves	54	63	49	39	69	86
Borrowings	31	25	7	6	8	8
Other Liabilities	52	83	29	19	18	16
Total Liabilities	162	196	110	90	124	140
Fixed Assets	108	110	15	14	14	13
CWIP	1	15	0	0	0	1
Investments	0	0	64	43	74	86
Other Assets	54	71	31	34	36	40
Total Assets	162	196	110	90	124	140

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	4	-37	-14	-10	3
Cash from Investing Activity +	-5	-25	0	0	-45
Cash from Financing Activity +	1	64	11	10	42
Net Cash Flow	0	2	-3	0	-0
Free Cash Flow	-1	-62	-15	-10	2
CFO/OP	1,519%	261%	48%	56%	-26%

Free Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-30.00	-39.00	-37.00	-24.00	-16.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	64.73	70.69	73.64	74.94	88.38
Inventory Days	177.86	156.51	79.89	60.49	62.10
Days Payable	233.26	159.24	165.21	97.25	91.94
Cash Conversion Cycle	9.34	67.96	-11.69	38.18	58.54
Working Capital Days	-84.81	33.99	-37.48	33.57	43.28
ROCE %		-15.50%	-30.45%	-24.70%	-9.90%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	66.41%	66.41%	63.59%	63.59%	63.59%	63.59%	63.59%	59.06%	52.62%	52.62%	52.62%	52.62%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.01%	0.05%	0.00%	0.01%	0.09%
DIIs	0.00%	0.00%	2.46%	3.86%	3.86%	3.86%	3.86%	3.86%	10.38%	10.38%	10.38%	10.38%
Public	33.59%	33.58%	33.94%	32.56%	32.55%	32.55%	32.53%	37.08%	36.95%	37.00%	37.00%	36.91%
No. of Shareholders	10,709	11,216	10,686	10,028	11,432	11,543	11,282	10,521	10,537	10,317	10,078	10,532

Shareholding Pattern Chart

No. of Shareholders

Brooks Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Quant Business Cycle Fund	528,937	0.84	6.69	528,937	2025-04-22 17:25:39	0%
Quant Healthcare Fund	276,708	1.99	3.5	276,708	2025-04-22 17:25:39	0%
Quant Small Cap Fund	187,346	0.02	2.37	187,346	2025-04-22 17:25:39	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-3.72	-7.65	-12.57	-7.82	-7.84
Diluted EPS (Rs.)	-3.72	-7.65	-12.57	-7.82	-7.84
Cash EPS (Rs.)	1.57	1.26	-8.39	-4.84	-4.95
Book Value[Excl.RevalReserv]/Share (Rs.)	33.30	24.99	29.94	54.37	32.04
Book Value[Incl.RevalReserv]/Share (Rs.)	33.30	24.99	29.94	54.37	32.04
Revenue From Operations / Share (Rs.)	28.03	30.28	25.59	36.87	31.27
PBDIT / Share (Rs.)	1.98	1.59	-10.61	-5.44	0.50
PBIT / Share (Rs.)	1.43	0.91	-13.46	-8.42	-2.38
PBT / Share (Rs.)	1.08	0.59	-14.20	-9.67	-3.64
Net Profit / Share (Rs.)	1.02	0.58	-11.23	-7.82	-7.84
NP After MI And SOA / Share (Rs.)	-3.38	-7.46	-8.46	-6.55	-7.84
PBDIT Margin (%)	7.05	5.24	-41.47	-14.76	1.62
PBIT Margin (%)	5.11	3.01	-52.59	-22.83	-7.62
PBT Margin (%)	3.86	1.95	-55.48	-26.23	-11.63
Net Profit Margin (%)	3.65	1.92	-43.89	-21.20	-25.07
NP After MI And SOA Margin (%)	-12.07	-24.64	-33.06	-17.77	-25.08
Return on Networth / Equity (%)	-10.15	-29.87	-28.26	-25.67	-24.47
Return on Capital Employeed (%)	4.18	3.56	-43.41	-14.14	-5.98
Return On Assets (%)	-8.05	-21.66	-19.06	-8.26	-11.95
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.14	0.18
Total Debt / Equity (X)	0.06	0.07	0.07	0.38	0.35
Asset Turnover Ratio (%)	0.77	0.79	0.41	0.57	0.00
Current Ratio (X)	1.48	1.35	0.83	1.25	0.78
Quick Ratio (X)	1.08	0.93	0.49	0.68	0.41
Inventory Turnover Ratio (X)	8.78	4.28	2.14	2.31	0.00
Interest Coverage Ratio (X)	5.66	4.94	-12.01	-4.34	0.40
Interest Coverage Ratio (Post Tax) (X)	3.93	2.81	-11.87	-5.24	-5.25
Enterprise Value (Cr.)	322.19	247.92	159.23	271.01	179.90
EV / Net Operating Revenue (X)	3.90	3.12	2.52	2.98	2.33
EV / EBITDA (X)	55.34	59.41	-6.07	-20.15	143.19
MarketCap / Net Operating Revenue (X)	3.84	3.06	2.45	1.97	1.99
Price / BV (X)	3.23	3.71	2.09	2.84	1.94
Price / Net Operating Revenue (X)	3.84	3.06	2.45	1.97	1.99
EarningsYield	-0.03	-0.08	-0.13	-0.09	-0.12

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Village Kishanpura,. Solan District Himachal Pradesh 174101	Contact not found

Management
Name	Position Held
Mr. Bhushan Singh Rana	Whole Time Director
Mr. Jitendra Pratap Singh	Whole Time Director
Mr. Durga Shankar Maity	Whole Time Director
Mr. Manav Mahajan	Independent Director
Mr. Lalit Mahajan	Independent Director
Dr. Usha Singh	Independent Director

FAQ

What is the intrinsic value of Brooks Laboratories Ltd and is it undervalued?

As of 05 May 2026, Brooks Laboratories Ltd's intrinsic value is ₹76.55, which is 40.46% higher than the current market price of ₹54.50, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (12.2 %), book value (₹39.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Brooks Laboratories Ltd?

Brooks Laboratories Ltd is trading at ₹54.50 as of 05 May 2026, with a FY2026-2027 high of ₹166 and low of ₹36.3. The stock is currently near its 52-week low. Market cap stands at ₹159 Cr..

How does Brooks Laboratories Ltd's P/E ratio compare to its industry?

Brooks Laboratories Ltd has a P/E ratio of 7.37, which is below the industry average of 60.16. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Brooks Laboratories Ltd financially healthy?

Key indicators for Brooks Laboratories Ltd: ROCE of 9.93 % is on the lower side compared to the industry average of 16.48%. Dividend yield is 0.00 %.

Is Brooks Laboratories Ltd profitable and how is the profit trend?

Brooks Laboratories Ltd reported a net profit of ₹-10 Cr in Mar 2025 on revenue of ₹83 Cr. Compared to ₹-19 Cr in Mar 2022, the net profit shows a mixed trend.

Does Brooks Laboratories Ltd pay dividends?

Brooks Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹54.50. The company is currently not paying meaningful dividends.